Pfizer: Early Look Shows COVID-19 Vaccine is 90% Effective
Share
Tweet
November 11, 2020
Drugmaker on pace to seek approval later this month
By Tom Howell Jr. - The Washington Times
A coronavirus vaccine from Pfizer proved more than 90% effective in a preliminary analysis of a trial involving thousands of enrollees, a major milestone in the race for shots that can reel in the pandemic.
The drugmaker said it tallied 94 infections in trial participants and looked at who received the vaccine, versus the placebo, to determine its efficacy. Recipients achieved protection 28 days after the second dose of the vaccine.
“Today is a great day for science and humanity. The first set of...
For access to this article please
sign in or
subscribe.
Reader Comments(0)